Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease

Post time 2022-5-15 18:54:37

journal：Amyloid

Authors：Efstathios Kastritis; Pantelis Rousakis; Ioannis V. Kostopoulos; Maria Gavriatopoulou; Foteini Theodorakakou; Despina Fotiou; Ioanna Dialoupi; Magdalini Migkou; Maria Roussou; Nikolaos Kanellias; Maria-Irini Tselegkidi; Evangelos Eleutherakis-Papaiakovou; Asimina Papanikolaou; Charikleia Gakiopoulou; Erasmia Psimenou; Marylin Spyropoulou-Vlachou; Anastasia Gatou; Evangelos Terpos; Ourania Tsitsilonis; Meletios A. Dimopoulos

Published date：2021-10-2

DOI：10.1080/13506129.2021.1971192

Article link：http://dx.doi.org/10.1080/13506129.2021.1971192

Article Source：Informa UK Limited。

Remark：

Post time 2022-5-15 18:54:38

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Taylor&Francis] Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Taylor&Francis] Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Taylor&Francis] Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease